Sensus Healthcare Q1 2024 GAAP EPS $0.14 Beats $(0.06) Estimate, Sales $10.663M Beat $4.120M Estimate

5/9/24 5:33:24 PM ET

Medical/Dental Instruments

Health Care

Get the next $SRTS alert in real time by email

Sensus Healthcare (NASDAQ:SRTS) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $(0.06) by 333.33 percent. This is a 216.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $10.663 million which beat the analyst consensus estimate of $4.120 million by 158.81 percent. This is a 212.33 percent increase over sales of $3.414 million the same period last year.

Get the next $SRTS alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SRTS

Date	Price Target	Rating	Analyst
11/15/2024	$12.00 → $14.00	Buy	Maxim Group
3/3/2022	$12.00 → $13.00	Buy	HC Wainwright & Co.
2/14/2022	$10.00 → $12.00	Buy	HC Wainwright & Co.
12/2/2021	$9.00 → $10.00	Buy	HC Wainwright & Co.
11/5/2021	$7.00 → $9.00	Buy	HC Wainwright & Co.
8/6/2021	$6.00 → $7.00	Buy	HC Wainwright & Co.

More analyst ratings

Sensus Healthcare Announces Retirement of Director Samuel O'Rear
BOCA RATON, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Samuel O'Rear will not stand for reelection to the Company's Board of Directors at the Company's 2024 annual meeting of stockholders. Mr. O'Rear has been a Director of Sensus Healthcare since 2012. As previously announced, on January 11, 2024 the Board of Directors of Sensus Healthcare appointed Michael J. Sardano, President and General Counsel of Sensus Healthcare, as a Director, effective today. "Sam has been inv
2/1/24 8:00:00 AM ET
$SRTS
Medical/Dental Instruments
Health Care
Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions
BOCA RATON, Fla, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces the following promotions, all effective immediately: Vice President and General Counsel Michael J. Sardano has been promoted to President and General CounselSales Manager Christopher Machuzak has been promoted to Vice President of Sales for the West CoastSoutheast Regional Sales Manager Jeffrey Starling has been promoted to Vice President of Sales for the East Coast In addition, the Company announces the retirement of Steve Cohen, Executive Vice Pre
1/31/22 4:05:00 PM ET
$SRTS
Medical/Dental Instruments
Health Care
Sensus Healthcare Engages Ekpac Healthcare Ltd. as New Exclusive Distributor in China for SRT-100™ Systems
BOCA RATON, Fla., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that it has entered into a new exclusive distribution agreement with Ekpac Healthcare Ltd. to market Sensus SRT-100™ systems in China and Hong Kong. This agreement is effective as of January 1, 2021. Sensus currently has 40 units installed throughout China in public and private hospitals as well as private clinics. It expects this relationship to accelerate SRT-100 unit population in the region. SRT-100 systems utilize S
12/15/20 8:00:00 AM ET
$SRTS
Medical/Dental Instruments
Health Care

REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter
This revised news release replaces the one issued on November 14, 2024, contains several non-financial changes throughout and removes the name of and references to a new customer, at the customer's request. The agreement with the new customer remains in effect. Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year ago Expects to have more than 50 IG-SRT Systems signed under the Fair Deal Agreement recurring-revenue program by the end of the year BOCA RATON, Fla, Nov. 17, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializin
11/17/24 8:32:25 PM ET
$SRTS
Medical/Dental Instruments
Health Care
Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter
Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year agoSigned a Fair Deal Agreement with Platinum Dermatology, a leading dermatology network with 130 clinics across the U.S. Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces financial results for the three and nine months ended September 30, 2
11/14/24 12:06:41 PM ET
$SRTS
Medical/Dental Instruments
Health Care
Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024
BOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 14, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones. Participants are encouraged to pre-register for the conference call using this link. Upon registration participants will receive a unique dial-in number that will permit them to bypass
10/31/24 8:00:00 AM ET
$SRTS
Medical/Dental Instruments
Health Care

REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter
This revised news release replaces the one issued on November 14, 2024, contains several non-financial changes throughout and removes the name of and references to a new customer, at the customer's request. The agreement with the new customer remains in effect. Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year ago Expects to have more than 50 IG-SRT Systems signed under the Fair Deal Agreement recurring-revenue program by the end of the year BOCA RATON, Fla, Nov. 17, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializin
11/17/24 8:32:25 PM ET
$SRTS
Medical/Dental Instruments
Health Care
Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter
Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year agoSigned a Fair Deal Agreement with Platinum Dermatology, a leading dermatology network with 130 clinics across the U.S. Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces financial results for the three and nine months ended September 30, 2
11/14/24 12:06:41 PM ET
$SRTS
Medical/Dental Instruments
Health Care
Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024
BOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 14, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones. Participants are encouraged to pre-register for the conference call using this link. Upon registration participants will receive a unique dial-in number that will permit them to bypass
10/31/24 8:00:00 AM ET
$SRTS
Medical/Dental Instruments
Health Care

HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Raises Price Target to $10
HC Wainwright & Co. analyst Yi Chen maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target from $8 to $10.
5/13/24 7:04:54 AM ET
$SRTS
Medical/Dental Instruments
Health Care
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results. Diodes posted adjusted earnings of 28 cents per share, missing market estimates of 31 cents per share. The company's quarterly sales came in at $301.97 million missing expectations of $305.01 million, according to data from Benzinga Pro. Diodes shares dipped 9.8% to $68.99 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Novavax, Inc. (NASDAQ:NVAX) shares jumped 139% to $10.73 after the company and Sanofi announced a co-exclusive licensing agreement to commercialize a COVID-19 vaccine and d
5/10/24 12:44:44 PM ET
$ACIC
$ADMA
$AEHL
$AFRM
Property-Casualty Insurers
Finance
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Novavax (NASDAQ:NVAX) stock increased by 110.7% to $9.42 during Friday's regular session. The market value of their outstanding shares is at $1.3 billion. The company's, Q1 earnings came out today. Portage Biotech (NASDAQ:PRTG) stock increased by 57.97% to $0.41. The market value of their outstanding shares is at $8.1 million. ITeos Therapeutics (NASDAQ:ITOS) stock rose 46.92% to $17.91. The company's market cap stands at $644.1 million. As per the press release, Q1 earnings came out today. Sensus Healthcare (NASDAQ:SRTS) stock moved upwards by 37.87% to $5.25. The company's market cap stands at $86.1 million. As per the press release, Q1 earnings came out yesterday. Cardio Diag
5/10/24 12:31:07 PM ET
$BFRI
$CDIO
$GRTS
$IOVA
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Biological Products (No Diagnostic Substances)

Sensus Healthcare Q1 2024 GAAP EPS $0.14 Beats $(0.06) Estimate, Sales $10.663M Beat $4.120M Estimate

Chat with this insight

Recent Analyst Ratings for $SRTS

$SRTS SEC Filings

Sensus Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

SEC Form 10-Q filed by Sensus Healthcare Inc.

Sensus Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$SRTS Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Maxim Group reiterated coverage on Sensus Healthcare with a new price target

HC Wainwright & Co. reiterated coverage on Sensus Healthcare with a new price target

HC Wainwright & Co. reiterated coverage on Sensus Healthcare with a new price target

$SRTS Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by Sensus Healthcare Inc. (Amendment)

SEC Form SC 13G/A filed by Sensus Healthcare Inc. (Amendment)

SEC Form SC 13G/A filed by Sensus Healthcare Inc. (Amendment)

$SRTS Leadership Updates

Live Leadership Updates

$SRTS Press Releases

Fastest customizable press release news feed in the world

$SRTS Financials

Live finance-specific insights

$SRTS Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$SRTS Market Insights

Live Market Insights

Sensus Healthcare Announces Retirement of Director Samuel O'Rear

Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions

Sensus Healthcare Engages Ekpac Healthcare Ltd. as New Exclusive Distributor in China for SRT-100™ Systems

REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024

REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024

CHIEF FINANCIAL OFFICER Rampolla Javier covered exercise/tax liability with 3,935 shares, decreasing direct ownership by 9% to 40,244 units (SEC Form 4)

PRESIDENT AND GENERAL COUNSEL Sardano Michael covered exercise/tax liability with 3,935 shares, decreasing direct ownership by 5% to 74,839 units (SEC Form 4)

Director Mccall William H disposed of 325,723 shares (SEC Form 4)

HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Raises Price Target to $10

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

12 Health Care Stocks Moving In Friday's Intraday Session

Recent Analyst Ratings for
$SRTS

$SRTS
SEC Filings

$SRTS
Analyst Ratings

$SRTS
Large Ownership Changes

$SRTS
Leadership Updates

$SRTS
Press Releases

$SRTS
Financials

$SRTS
Insider Trading

$SRTS
Market Insights